Gap analysis of a US CMC data package for a European submission
Challenge
A small regulatory company had been commissioned to review the development data package available from a US biotech company for a liquid inhalation product, with a view to using the data package for a New Drug Application submission. The regulatory company approached us asking for a gap analysis of the data package in relation to a European product license submission.
Solution
Our CMC consultant reviewed the CMC data package and provided the analysis, enabling the client to gain a clear picture of any gaps and respond as necessary before making the submission.
Related Case Studies
Explore similar engagements and see how we've helped other clients achieve their goals.
ISO13485 Audit by medical device consultant
A blue-chip consumer healthcare products company asked Alacrita to provide a medical device consultant to audit the mainland Europe manufacturing site of a potential supplier...
Gene therapy preclinical, CMC, & regulatory strategy
Challenge: An early-stage biotechnology startup company reached out to Alacrita for critical support of its two lead AAV-delivered gene therapy programs. As a virtual company, the...
Interested in Learning More?
Contact us to discuss how we can support your project with similar expertise.